Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

SRPTSarepta Therapeutics, Inc.

$2B

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$34M

Operating Income

-$57M

Net Income

-$57M

EPS (Diluted)

$-1.18

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$62M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$487M

Total Liabilities

$79M

Stockholders' Equity

$409M

Cash & Equivalents

$395M

← FY 2016 All Quarters Q4 2016 →

SRPT Q3 2016 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena